Literature DB >> 21734181

Progressive multifocal leukoencephalopathy in a patient without immunodeficiency.

I L Tan1, I J Koralnik, J A Rumbaugh, P C Burger, A King-Rennie, J C McArthur.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21734181      PMCID: PMC3136053          DOI: 10.1212/WNL.0b013e318225ab3f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

Review 1.  Progressive multifocal leukoencephalopathy.

Authors:  J R Berger; E O Major
Journal:  Semin Neurol       Date:  1999       Impact factor: 3.420

Review 2.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

3.  Autopsy case of the cerebellar form of progressive multifocal leukoencephalopathy without immunodeficiency.

Authors:  Yoshifumi Arai; Yoshihiro Tsutsui; Kazuo Nagashima; Yuichiro Shinmura; Tomoki Kosugi; Masakazu Wakai; Hirofumi Nishikage; Junnosuke Yamamoto
Journal:  Neuropathology       Date:  2002-03       Impact factor: 1.906

4.  Determinants of survival in progressive multifocal leukoencephalopathy.

Authors:  A Marzocchetti; T Tompkins; D B Clifford; R T Gandhi; S Kesari; J R Berger; D M Simpson; M Prosperi; A De Luca; I J Koralnik
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

Review 5.  Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression.

Authors:  Sarah Gheuens; Gerald Pierone; Patrick Peeters; Igor J Koralnik
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-10-14       Impact factor: 10.154

6.  PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids.

Authors:  K Tan; R Roda; L Ostrow; J McArthur; A Nath
Journal:  Neurology       Date:  2009-01-07       Impact factor: 9.910

7.  Identification and characterization of mefloquine efficacy against JC virus in vitro.

Authors:  Margot Brickelmaier; Alexey Lugovskoy; Ramya Kartikeyan; Marta M Reviriego-Mendoza; Norm Allaire; Kenneth Simon; Richard J Frisque; Leonid Gorelik
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

  7 in total
  9 in total

Review 1.  Persistence and pathogenesis of the neurotropic polyomavirus JC.

Authors:  Hassen S Wollebo; Martyn K White; Jennifer Gordon; Joseph R Berger; Kamel Khalili
Journal:  Ann Neurol       Date:  2015-03-06       Impact factor: 10.422

2.  GRK2 mediates β-arrestin interactions with 5-HT2 receptors for JC polyomavirus endocytosis.

Authors:  Colleen L Mayberry; Michael P Wilczek; Tristan M Fong; Sarah L Nichols; Melissa S Maginnis
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

3.  Flaccid Brachial Monoplegia As Initial Presentation in a Patient With Progressive Multifocal Leukoencephalopathy.

Authors:  Lisa B Shields; Vasudeva G Iyer; Hilary A Highfield; Yi Ping Zhang; Christopher B Shields
Journal:  Cureus       Date:  2022-04-17

4.  Rearrangement in the Hypervariable Region of JC Polyomavirus Genomes Isolated from Patient Samples and Impact on Transcription Factor-Binding Sites and Disease Outcomes.

Authors:  Michael P Wilczek; Aiden M C Pike; Sophie E Craig; Melissa S Maginnis; Benjamin L King
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

5.  JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin.

Authors:  Colleen L Mayberry; Ashley N Soucy; Conner R Lajoie; Jeanne K DuShane; Melissa S Maginnis
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

6.  Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis.

Authors:  Boleslaw Lach; Barbara Connolly; Christian Wüthrich; Igor J Koralnik
Journal:  Neuropathology       Date:  2013-05-20       Impact factor: 1.906

7.  Progressive multifocal leukoencephalopathy in a 62-year-old immunocompetent woman.

Authors:  Venkata C Gourineni; Tristan Juvet; Yogesh Kumar; Doru Bordea; Kanaga N Sena
Journal:  Case Rep Neurol Med       Date:  2014-02-23

8.  PI3K/AKT/mTOR Signaling Pathway Is Required for JCPyV Infection in Primary Astrocytes.

Authors:  Michael P Wilczek; Francesca J Armstrong; Colleen L Mayberry; Benjamin L King; Melissa S Maginnis
Journal:  Cells       Date:  2021-11-18       Impact factor: 6.600

9.  The MAPK/ERK Pathway and the Role of DUSP1 in JCPyV Infection of Primary Astrocytes.

Authors:  Michael P Wilczek; Francesca J Armstrong; Remi P Geohegan; Colleen L Mayberry; Jeanne K DuShane; Benjamin L King; Melissa S Maginnis
Journal:  Viruses       Date:  2021-09-14       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.